Skip to main content
S 585 117th Congress Senate Sports and Recreation Alternative dispute resolution, mediation, arbitration Athletes Child health Congressional oversight Criminal investigation, prosecution, interrogation Drug safety, medical device, and laboratory regulation Drug, alcohol, tobacco use Due process and equal protection International law and treaties International organizations and cooperation Medical tests and diagnostic methods Olympic games

United States Anti-Doping Agency Reauthorization Act of 2021

Introduced: March 3, 2021 Introduced by: Moran, Jerry Republican · Kansas See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 3, 2021
Read twice and referred to the Committee on Commerce, Science, and Transportation.
Mar 3, 2021
Introduced in Senate
 Plain-English summary Congressional Research Service

United States Anti-Doping Agency Reauthorization Act of 2021

This bill authorizes appropriations for the U.S. Anti-Doping Agency (USADA) through FY2030.

The bill adds requirements that USADA

  • be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and
  • promote a positive youth sport experience by using a portion of its funding to provide educational materials on sportsmanship, character building, and healthy performance for those participating in youth sports.

The bill requires any action taken by USADA to enforce a policy, procedure, or requirement against a person with respect to a violation of federal law, including an investigation, disciplinary action, sanction, or any other administrative action, to be carried out in a manner that provides due process protection.

The Department of Justice, the Department of Homeland Security, and the Food and Drug Administration must provide to USADA information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

What's happening now March 3, 2021

Read twice and referred to the Committee on Commerce, Science, and Transportation.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1